Cargando…

Early Changes of Neuromuscular Transmission in the SOD1(G93A) Mice Model of ALS Start Long before Motor Symptoms Onset

Amyotrophic lateral sclerosis is characterized by a progressive degeneration of the corticospinal tract motor neurons. Growing evidence suggests that degeneration may begin at the distal axon proceeding in a dying-back pattern. It seemed therefore of interest to investigate synaptic transmission at...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rocha, Mariana C., Pousinha, Paula A., Correia, Alexandra M., Sebastião, Ana M., Ribeiro, Joaquim A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3764017/ https://www.ncbi.nlm.nih.gov/pubmed/24040091 http://dx.doi.org/10.1371/journal.pone.0073846

Ejemplares similares

Adenosine A(2A) Receptors Activation Facilitates Neuromuscular Transmission in the Pre-Symptomatic Phase of the SOD1(G93A) ALS Mice, but Not in the Symptomatic Phase
por: Nascimento, Filipe, et al.
Publicado: (2014)

Neuromuscular effects of G93A-SOD1 expression in zebrafish
por: Sakowski, Stacey A, et al.
Publicado: (2012)

Development of abnormalities at the neuromuscular junction in the SOD1-G93A mouse model of ALS: dysfunction then disruption of postsynaptic structure precede overt motor symptoms
por: McIntosh, Jayne, et al.
Publicado: (2023)

Forelimb Resistance Exercise Protects Against Neuromuscular Junction Denervation in the SOD1-G93A Rat Model of ALS
por: Nishimune, Hiroshi, et al.
Publicado: (2022)

Microglia Morphological Changes in the Motor Cortex of hSOD1(G93A) Transgenic ALS Mice
por: Migliarini, Sara, et al.
Publicado: (2021)

Changes in adenosine receptors and neurotrophic factors in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis: Modulation by chronic caffeine
por: Rei, Nádia, et al.
Publicado: (2022)

Tempol improves neuroinflammation and delays motor dysfunction in a mouse model (SOD1(G93A)) of ALS
por: Chiarotto, Gabriela Bortolança, et al.
Publicado: (2019)

Effects of RAGE inhibition on the progression of the disease in hSOD1(G93A) ALS mice
por: Liu, Liping, et al.
Publicado: (2020)

Measuring Neuromuscular Junction Functionality in the SOD1(G93A) Animal Model of Amyotrophic Lateral Sclerosis
por: Rizzuto, Emanuele, et al.
Publicado: (2015)

Influence of Methylene Blue on Microglia-Induced Inflammation and Motor Neuron Degeneration in the SOD1(G93A) Model for ALS
por: Dibaj, Payam, et al.
Publicado: (2012)

Calretinin and Neuropeptide Y interneurons are differentially altered in the motor cortex of the SOD1(G93A) mouse model of ALS
por: Clark, Rosemary M., et al.
Publicado: (2017)

Golgi fragmentation precedes neuromuscular denervation and is associated with endosome abnormalities in SOD1-ALS mouse motor neurons
por: van Dis, Vera, et al.
Publicado: (2014)

A closer look at the SOD1(G93Adl) mouse model of ALS
Publicado: (2011)

Genetic Biomarkers for ALS Disease in Transgenic SOD1(G93A) Mice
por: Calvo, Ana C., et al.
Publicado: (2012)

Combined intramuscular and intraspinal transplant of bone marrow cells improves neuromuscular function in the SOD1(G93A) mice
por: Martínez-Muriana, Anna, et al.
Publicado: (2020)

Argonaute 2 is lost from neuromuscular junctions affected with amyotrophic lateral sclerosis in SOD1(G93A) mice
por: Shapiro, Dillon, et al.
Publicado: (2022)

Histamine Is an Inducer of the Heat Shock Response in SOD1-G93A Models of ALS
por: Apolloni, Savina, et al.
Publicado: (2019)

Verapamil Ameliorates Motor Neuron Degeneration and Improves Lifespan in the SOD1(G93A) Mouse Model of ALS by Enhancing Autophagic Flux
por: Zhang, Xiaojie, et al.
Publicado: (2019)

Skeletal-Muscle Metabolic Reprogramming in ALS-SOD1(G93A) Mice Predates Disease Onset and Is A Promising Therapeutic Target
por: Scaricamazza, Silvia, et al.
Publicado: (2020)

Mitochondria-Targeted Catalase Reverts the Neurotoxicity of hSOD1(G93A) Astrocytes without Extending the Survival of ALS-Linked Mutant hSOD1 Mice
por: Pehar, Mariana, et al.
Publicado: (2014)

SOD1 silencing in motoneurons or glia rescues neuromuscular function in ALS mice
por: Dirren, Elisabeth, et al.
Publicado: (2015)

Protocatechuic Acid Extends Survival, Improves Motor Function, Diminishes Gliosis, and Sustains Neuromuscular Junctions in the hSOD1(G93A) Mouse Model of Amyotrophic Lateral Sclerosis
por: Koza, Lilia A., et al.
Publicado: (2020)

Chronic administration of P2X7 receptor antagonist JNJ-47965567 delays disease onset and progression, and improves motor performance in ALS SOD1(G93A) female mice
por: Ruiz-Ruiz, Cristina, et al.
Publicado: (2020)

Decreased signalling of EphA4 improves functional performance and motor neuron survival in the SOD1(G93A) ALS mouse model
por: Zhao, J., et al.
Publicado: (2018)

Inducible EphA4 knockout causes motor deficits in young mice and is not protective in the SOD1(G93A) mouse model of ALS
por: Dominguez, Sara L., et al.
Publicado: (2020)

Cortical glia in SOD1(G93A) mice are subtly affected by ALS-like pathology
por: Filipi, Tereza, et al.
Publicado: (2023)

Oral Treatment with RD2RD2 Impedes Development of Motoric Phenotype and Delays Symptom Onset in SOD1(G93A) Transgenic Mice
por: Post, Julia, et al.
Publicado: (2021)

Early detachment of neuromuscular junction proteins in ALS mice with SODG93A mutation
por: Narai, Hisashi, et al.
Publicado: (2009)

Th17 Cell Response in SOD1(G93A) Mice following Motor Nerve Injury
por: Ni, Allen, et al.
Publicado: (2016)

R13 preserves motor performance in SOD1(G93A) mice by improving mitochondrial function
por: Li, Xiao, et al.
Publicado: (2021)

ALS-associated mutant SOD1(G93A )causes mitochondrial vacuolation by expansion of the intermembrane space and by involvement of SOD1 aggregation and peroxisomes
por: Higgins, Cynthia MJ, et al.
Publicado: (2003)

Overexpression of survival motor neuron improves neuromuscular function and motor neuron survival in mutant SOD1 mice
por: Turner, Bradley J., et al.
Publicado: (2014)

Subpial delivery of adeno-associated virus 9-synapsin-caveolin-1 (AAV9-SynCav1) preserves motor neuron and neuromuscular junction morphology, motor function, delays disease onset, and extends survival in hSOD1(G93A) mice
por: Wang, Shanshan, et al.
Publicado: (2022)

Early Detection of Motor Dysfunction in the SOD1(G93A) Mouse Model of Amyotrophic Lateral Sclerosis (ALS) Using Home Cage Running Wheels
por: Bennett, Ellen J., et al.
Publicado: (2014)

Presymptomatic Treatment with Acetylcholinesterase Antisense Oligonucleotides Prolongs Survival in ALS (G93A-SOD1) Mice
por: Marc, Gotkine, et al.
Publicado: (2013)

Electrophysiologic Biomarkers for Assessing Disease Progression and the Effect of Riluzole in SOD1 G93A ALS Mice
por: Li, Jia, et al.
Publicado: (2013)

Actions of the antihistaminergic clemastine on presymptomatic SOD1-G93A mice ameliorate ALS disease progression
por: Apolloni, Savina, et al.
Publicado: (2016)

Impact of Pharmacological Inhibition of Hydrogen Sulphide Production in the SOD1G93A-ALS Mouse Model
por: Spalloni, Alida, et al.
Publicado: (2019)

The Involvement of RAGE and Its Ligands during Progression of ALS in SOD1 G93A Transgenic Mice
por: Nowicka, Natalia, et al.
Publicado: (2022)

Assessing the therapeutic impact of resveratrol in ALS SOD1-G93A mice with electrical impedance myography
por: Nagy, Janice A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r5jtga9ks84gv9e71dl8hj1fgu